SMLR Semler: Market Capitalization to Book Value Ratio

Semler Scientific (SMLR) - corporate logo

Semler Scientific, Inc. (SMLR) maintains its position in the niche of IT devices for detecting vascular pathologies, utilizing a Bitcoin treasury strategy to drive profit growth, which currently stands at 0.66. The company provides US medical centers with mobile diagnostic complexes featuring cloud data storage. This chart visualizes the asset's price action. Product excellence is ensured through assembly automation and the implementation of machine vision systems.

SMLR (Semler) Market Capitalization to Book Value history from 07/04/2022 to 01/31/2026
Product sample of Semler Scientific Corp

The resilience of Semler Scientific, Inc. (SMLR) to volatility is supported by the synergy between diagnostic software sales and aggressive Bitcoin accumulation. By analyzing the chart of the market-to-book ratio, an investor assesses the market value premium over net assets, which allows for the differentiation of real capitalization growth from speculative optimism, thereby determining the degree of market confidence in the company's balance sheet management strategy.

Direct competitors

Market Value to Book Value Ratio Abbott Laboratories ABT|thermofisher.com (TMO) - Market Value to Book Value|Market Capitalization to Book Value Ratio GE HealthCare Technologies (GEHC)|Capitalization to Book Value Ratio Mettler-Toledo|WAT (Waters Corp.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Bio-Techne Inc. (TECH)|Market Capitalization to Book Value Ratio BRKR (Bruker Corporation)|Market Capitalization to Book Value Ratio azenta.com AZTA|Market Capitalization to Book Value Ratio VREX|BFLY: Market Value to Equity Ratio|Market Value to Book Value Ratio Mesa Labs Corp|QSI (Quantum-Si Corporation) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio NNOX (Nano-X Imaging Ltd.)|Market-to-Book Ratio QTRX|MASS (908 Devices) - Market Value to Book Value Ratio|Market Capitalization to Book Value capsovision.com CV|Market Cap to Net Assets Ratio MaxCyte, Inc (MXCT)|Market Cap to Book Value Multiple Rapid Micro Biosystems Inc. RPID|Market Capitalization to Book Value Ratio SEER (Seer, Inc.)|HYPR - Market Capitalization to Book Value|FONR (FONAR) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Daxor|MDAI - Market Cap to Net Assets Ratio|Market Value to Book Value VIVS|Market Value to Book Value Ratio ACON (Aclarion)|Market Cap to Net Assets Ratio akoyabio.com (AKYA)|THMO: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Market Capitalization to Book Value Ratio